An early small study in China had appeared promising, but the drug showed no benefit over a placebo in a larger US study of 276 patients with "severe" diseasefrom The News International - Health https://ift.tt/3bJGYYr
An early small study in China had appeared promising, but the drug showed no benefit over a placebo in a larger US study of 276 patients with "severe" disease
Comments
Post a Comment